Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07528079) titled 'Organoid-based Sensitivity-guided Chemotherapy for Advanced / Refractory Pediatric Tumors' on April 7.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Shanghai Jiao Tong University School of Medicine
Condition:
Soft Tissue Sarcoma, Child
Intervention:
Drug: treatment based on the results of drug sensitivity analysis
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: April 1, 2026
Target Sample Size: 30
Countries of Recruitment:
China
To know more, visit http...